Vermont 2023-2024 Regular Session

Vermont House Bill H0222

Introduced
2/10/23  
Refer
2/10/23  
Refer
3/21/23  
Refer
3/22/23  
Engrossed
3/29/23  
Refer
3/31/23  
Report Pass
4/18/23  
Refer
4/18/23  
Refer
4/18/23  
Report Pass
4/20/23  
Report Pass
4/20/23  
Report Pass
4/21/23  
Report Pass
4/21/23  
Enrolled
4/25/23  
Enrolled
5/5/23  
Enrolled
5/12/23  

Caption

An act relating to reducing overdoses

Impact

The legislation is designed to significantly impact state laws regarding substance use disorder treatment and harm reduction strategies. It includes funding allocations for outreach and case management services, helping engage those with opioid use disorders. Additionally, the bill creates an Opioid Abatement Special Fund, aimed at utilizing settlement funds for prevention, intervention, and recovery services. This funding structure ensures that resources are directed toward effective programs designed to mitigate the ongoing crisis.

Summary

House Bill 222 (H0222) is focused on addressing the opioid crisis in Vermont through various measures aimed at reducing overdoses and supporting individuals with substance use disorders. The bill includes provisions for enhancing access to treatments for opioid addiction, such as medication-assisted treatment and eliminating prior authorization for these medications in certain contexts. Furthermore, it establishes a statewide program for the safe disposal of unused prescription drugs, needles, and syringes, which is critical for preventing accidental overdoses and ensuring community safety.

Sentiment

The sentiment surrounding H0222 is largely supportive among public health advocates, healthcare professionals, and community organizations who see it as a necessary step towards combating the opioid overdose epidemic. However, concerns remain among some legislators and constituents who worry about adequate oversight and the potential for unintended consequences related to expanded access to certain substances. The discussions have revealed a commitment to striking a balance between harm reduction and public safety.

Contention

Notable points of contention in the discussions around H0222 include the role of drug-checking services, with debates revolving around the legality and implications of providing such services without risk of legal repercussions for individuals seeking assistance. Furthermore, there are concerns about the operationalization of the proposed programs, especially regarding how effectively the state can manage and monitor the distribution of funds and services to ensure they meet community needs effectively.

Companion Bills

No companion bills found.

Previously Filed As

VT HB3375

STOP Fentanyl Overdoses Act of 2023 Support, Treatment, and Overdoses Prevention of Fentanyl Overdoses Act of 2023

VT SB1785

Stop Fentanyl Overdoses Act of 2023

VT HB6251

HERO Act Helping Educators Respond to Overdoses Act

VT H0705

An act relating to opioid overdose response training and the distribution of opioid antagonists

VT SB2976

Preventing Overdoses with Test Strips Act

VT HB1291

Stopping Overdoses of Fentanyl Analogues Act

VT HB5801

Preventing Overdoses with Test Strips Act

VT H0088

An act relating to reducing the imposition of cash bail

VT HB358

AN ACT relating to opioid overdose reversal agents.

VT H0072

An act relating to a harm-reduction criminal justice response to drug use

Similar Bills

CT HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

CT HB06856

An Act Concerning Substance Abuse And Opioid Overdose Prevention.

CA AB1037

Public health: substance use disorder.

CT HB07395

An Act Concerning Opioid Abuse And Treatment.

CT HB06913

An Act Concerning Opioids.

CT HB05430

An Act Concerning Opioids.

MA H4743

Relative to treatments and coverage for substance use disorder and recovery coach licensure

CT HB07052

An Act Preventing Prescription Opioid Diversion And Abuse.